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Introduction: A vaccine targeting high-risk human papillomavirus (HPV) strains can effectively 
prevent HPV-associated cervical cancer risk. However, many girls and women do not receive the 
vaccine, more often those impacted by health disparities associated with race and/or socioeconomic 
status. This same disparate population has also been shown to be at higher risk for cervical 
cancer. Many of these women also rely on the emergency department (ED) as a safety net for 
their healthcare. This study sought to gather information pertaining to HPV and cervical cancer 
risk factors, awareness of HPV and the vaccine, as well as HPV vaccine uptake in female patients 
presenting to an ED.   
Methods: We obtained 81 surveys completed by female ED patients. Demographics included age, 
race, income, insurance status, primary care provider status, and known cervical-cancer risk factors. 
Subsequent survey questions explored respondents’ knowledge, familiarity, and attitudes regarding 
HPV, cervical cancer, and the HPV vaccine, including vaccination uptake rates. We analyzed data 
using descriptive statistics and Fisher’s exact test. 
Results: Approximately one in seven respondents (14.8%) had never previously heard of HPV and 
32.1% were unaware of the existence of a HPV vaccine. Minority patients, including those who were 
Black and Hispanic patients, low income patients, and uninsured and publicly insured patients were 
less likely to be aware of HPV and the vaccine and likewise were less likely to be offered and receive 
the vaccine. More than 60% of all respondents (61.3%) had never previously been offered the 
vaccine, and only 24.7% of all respondents had completed the vaccine series. 
Conclusion: Female ED patients may represent an at-risk cohort with relatively low HPV awareness 
and low HPV vaccine uptake. The ED could represent a novel opportunity to access and engage 
high-risk HPV populations. [West J Emerg Med. 2020;21(2)203-208.]
INTRODUCTION
Human papillomavirus (HPV) is the most common 
sexually transmitted infection and the most common cause of 
cervical cancer and cervical cancer-related deaths in the United 
States (US).1-4 HPV infection and HPV-associated cervical 
cancer are preventable due to the advent of highly effective 
vaccines available since 2006. The Centers for Disease Control 
and Prevention (CDC), as well as the Advisory Committee 
on Immunization Practices, recommend the HPV vaccination 
series for girls aged 11 or 12 years of age, as well as females 
aged 13 to 26 not adequately vaccinated previously.1,5 In 
response to these recommendations, HPV awareness and 
vaccination rates have increased, but overall vaccination uptake 
remains well below national goals.6 
Most alarming, significant disparities in HPV vaccine 
knowledge and vaccine series completion exist among those 
with the highest rates of HPV infection, including racial 
minorities, the under- and uninsured, and the economically 
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Population Health Research Capsule
What do we already know about this issue?
Human papillomavirus (HPV) is the most 
common sexually transmitted infection in 
the US, responsible for over 90% of cervical 
cancer cases. HPV vaccine uptake is low. 
What was the research question?
Evaluate and characterize HPV awareness and 
vaccine rates in female patients presenting to 
the emergency department (ED).
What was the major finding of the study?
The female ED population represents a unique, 
at-risk cohort in regard to HPV and cervical-
cancer risk factors. 
How does this improve population health?
This study challenges emergency physicians to 
consider an expanded role as HPV educator 
and vaccine advocate, particularly for “at-
risk” patients. 
disadvantaged.7-11 Further, cervical cancer incidence and 
mortality are higher among Black and Hispanic women as 
compared to White women, and cervical cancer incidence has 
been shown to be nearly twice as high among those living in 
poverty.12 For these reasons, it is a national priority to raise HPV 
awareness and vaccination among these disproportionately 
affected populations.
Due to challenges accessing primary care, disparate 
populations may benefit from engagement in HPV awareness 
and screening in alternative venues.13 Emergency departments 
(ED) have previously been demonstrated to be high-yield 
and effective venues for raising awareness of similar silent, 
stigmatizing, and deadly conditions–specifically, human 
immunodeficiency virus (HIV) and hepatitis C virus (HCV).14,15 
Thus, it has been suggested that the ED be considered as an 
alternative setting for HPV education, screening, and vaccine 
administration in an effort to overcome barriers to HPV 
provision in all populations.16
We sought to measure and characterize HPV and cervical 
cancer awareness, risk factors, and HPV vaccination history 
among adult females presenting to an urban, academic ED. We 
hypothesized that female patients in the ED would demonstrate 
lower rates of HPV awareness and vaccination uptake than the 
general population.
METHODS
We performed a cross-sectional, survey-based study at 
the University of Alabama at Birmingham (UAB), an urban, 
academic ED in the Southeast US with an affiliated emergency 
medicine residency program and an annual volume of 
approximately 65,000, from June 1–August 31, 2016. The UAB 
Institutional Review Board approved the protocol. Adult female 
patients, aged 18-32, were recruited to participate in the survey 
during their ED visit. We selected the age of 32 as the upper age 
limit for survey engagement to align with the availability of the 
HPV vaccine and vaccine administration guidelines beginning 
in 2006.17 Trained female research assistants (RA) recruited 
applicable patients and administered the survey Monday 
through Friday, 9 am to 4 pm (a convenience sample). 
We collected 81 completed surveys in this pilot study 
to demonstrate feasibility. Exclusion criteria included the 
following: individuals who did not speak English or for whom 
communication barriers were present (eg, altered mental status, 
dementia); were medically or psychiatrically unstable; or who 
were undergoing active emergent evaluation or treatment; 
and individuals presenting for sexual assault. Subjects were 
recruited and administered the surveys in private rooms, and 
written informed consent was provided. RAs verbally delivered 
the survey questions in a casual interview style. 
The 21-item survey instrument was developed by the 
study authors with the intent to be expansive, capturing general 
HPV awareness as well as HPV vaccine uptake information, in 
addition to demographic factors to include pre-existing cervical-
cancer risk factors. While created de novo, the survey was 
influenced by previously published HPV awareness and attitude 
survey studies.12,16,18,19 The final survey (Appendix A) contained  
the following: demographic information; HPV infection and 
vaccine awareness; HPV vaccination history; HPV infection 
and cervical cancer risk factors. Survey questions met a SMOG 
(Simple Measure of Gobbledygook) reading index of 7th grade 
and a Gunning Fog score of 8.6, designating it “fairly easy to 
read.”20,21 The RA was allowed to clarify for the respondent any 
real-time questions regarding definitions and/or survey question 
verbiage as needed.  
We selected a $20,000 annual household income threshold 
to reflect the 2016 Federal Poverty Line (FPL), the minimum 
amount of gross income that a family needs for food, clothing, 
transportation, shelter, and other necessities, as determined 
by the Department of Health and Human Services.23 In 2016, 
the FPL for a two-person household was $16,020 and for a 
three-person household was $20,160. To effectively capture 
the majority of respondents and understand the effect of 
socioeconomic status, we selected a delineation of $20,000 for 
the purpose of this study.
We collected the project data in a secure REDCap 
database.22 We determined the proportion of participants 
acknowledging HPV awareness and prior vaccination stratified 
by age, gender, race, access to primary care, income, and 
medical insurance status, assessing non-random differences of 
association using Fisher’s exact test (STATA/IC, 15.1, College 
Station, Texas).
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RESULTS
A total of 81 surveys were completed. Participant 
demographics are displayed in Table 1. Insurance status 
information was unavailable for one respondent (0.05%); 
likewise, income information was unavailable for five 
respondents (6.2%), and primary care provider status was 
unavailable for one respondent (1.2%). Three respondents 
(3.7%) identified more than one locale where they routinely 
sought primary care services.
Selected survey question responses with demographic 
delineation are displayed in Table 2. Survey response data 
regarding HPV vaccination rates was available for 80 survey 
respondents. One respondent who had previously received the 
HPV vaccine and four who had not received the vaccine did not 
disclose or were unaware of their annual household income.
HPV awareness was significantly higher among White 
respondents (96.4%, p = .016) and those with higher annual 
income (96.9%, p = .020). Among respondents with awareness 
of HPV, however, additional understanding of its designation 
as a common sexually transmitted infection and its association 
with cervical cancer was generally mixed. White patients were 
more likely to be aware of the HPV-cervical cancer association 
(). HPV vaccine awareness was higher among patients with an 
established primary care provider (84.6%, p = .003) and lower 
among those publicly insured or uninsured (42.2%, p = .034) 
and those with lower annual household income (40.9%, p = 
.048).
Only 38.8% respondents reported ever being offered the 
HPV vaccine and 24.7% previously completed the vaccination 
series. Of those vaccinated for HPV, 78% reported receiving the 
vaccine at their primary care physician’s office. Notably, 12.5% 
of respondents reported declining a prior HPV vaccination. 
Of those age-eligible (n = 43) for HPV vaccination, 76% 
reported they would be comfortable initiating and receiving 
HPV vaccination in the ED.
A number of known cervical-cancer risk factors were 
also identified among respondents: inconsistent use of barrier 
contraceptive during sexual activity (59.5%); tobacco use 
(27.2%); pregnancy prior to age 17 (12.3%); and a family 
history of cervical cancer (7.6%) (Appendix C). 
DISCUSSION
In general, our survey respondents demonstrated a 
population with low HPV awareness and low HPV vaccination 
rates along with significant risk factors for HPV exposure 
and cervical cancer. The HPV vaccine series completion rate 
reported in this unique ED population was far below national 
vaccination rates. In 2017, 49% of US teens had completed 
the HPV vaccine series as compared to less than a quarter of 
our survey respondents.24 Racial and social inequities that have 
previously been associated with decreased vaccination rates 
in the primary care setting were echoed and, in some cases, 
amplified in this ED venue.7-11  
In addition, it is alarming to note the number of vaccine-
eligible women who reported they had never been counselled 
about nor offered the HPV vaccine, potentially because they did 
not have a primary care physician or the resources to see one 
regularly. Equally concerning was the nearly 13% refusal rate 
by those who had been offered the vaccine. Reasons given for 
declination were variable but predominantly included “I feel the 
illness is not severe or ‘bad enough’ to warrant vaccination,” 
and “The preservatives in the vaccines are dangerous.” 
This may represent lack of an established or primary care 
relationship to offer sufficient education regarding HPV, 
HPV’s direct association with cervical cancer, and vaccines in 
general.25 
The study population also demonstrated a low awareness 
of HPV’s direct correlation with cervical cancer along with a 
significant risk profile for cervical cancer. Thirty-five percent 
were unaware of the HPV-cervical cancer connection, with even 
higher percentages noted among Black patients (44.9%) and the 
uninsured (57.1%). This has been demonstrated previously and 
may represent the influence of socioeconomic determinants of 
health, which can affect primary care access and utilization of 
preventive health services.11,12,19 Likewise, prevalence of several 
cervical-cancer risk factors among respondents was noted to be 
high as compared to the general population including smoking 
tobacco (27.2% among respondents compared to 15.5% 
nationwide) and full-term pregnancy before age 17 (12.3% 
of respondents compared to 19 births per 1000 in the US in 
2017, or nearly seven times the national rate).26,27 The over-
representation of cervical-cancer risk factors in this population 
underscores a vulnerable, at-risk subset. 
The survey results highlight several potential engagement 
opportunites for emergency physicians (EP) to consider, 
including HPV awareness campaigns and ED-initiated HPV 
Race n = 81
Black or African American 50 (61.7%)
White or Caucasian 28 (34.6%)
Hispanic or Latina 3 (3.7%)
Insurance Status n = 80
Private 36 (45.0%)
Publicly insured or uninsured 44 (55.0%)
Income n = 76
<$20,000/year 44 (57.9%)
>$20,000/year 32 (42.1%)
Primary Care Provider Status n = 80
Established primary care 42 (52.5%)
Federally funded or “free” clinic 20 (25.0%)
Emergency department or urgent care 17 (21.25%)
None/other 5 (6.25%)
Table 1. Demographics of participants who completed a survey on 
human papillomavirus awareness.
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Yes
n (%)
No
n (%)
p-value
Have you heard of HPV? 69 (85.2) 12 (14.8)
Race
Black or African American 41 (82.0) 9 (18.0)
White or Caucasian 27 (96.4) 1 (3.6)
Hispanic or Latina 1 (33.3%) 2 (66.7%) .016
Insurance Status
Private insurance 34 (94.4) 2 (5.6)
Publicly Insured or Uninsured 35 (77.8) 10 (22.2) .057
Income
<$20,000/year 34 (77.3) 10 (22.7)
>$20,000/year 31 (96.9) 1 (3.1) .020
Primary Care Provider Status
Established PCP 37 (94.9) 2 (5.1)
Federally funded or “free” clinic 14 (73.7) 5 (26.3)
ED or Urgent Care 12 (80.0) 3 (20.0)
None or “Other” 4 (80.0) 1 (20.0) 0.072
Respondents who have received partial or complete HPV vaccination 23 (28.75) 57 (71.25)
Race 23 (28.75) 57 (71.25)
Black or African American 13 (26.0) 37 (74.0)
White or Causcasian 10 (37.0) 17 (63.0)  
Hispanic or Latina 0 (0) 3 (100) .437
Insurance Status
Private insurance 13 (36.1) 23 (63.9)
Publicly insured or uninsured 10 (22.7) 34 (77.3) .221
Income
<$20,000/year 9 (20.9) 34 (79.1)
>$20,000/year 13 (40.6) 19 (59.3) .077
Primary Care Provider Status
Established PCP 15 (35.7) 27 (64.3)
Federally funded or “free” clinic 2 (10.0) 18 (90.0)
ED or Urgent care 5 (29.4) 12 (70.6)
None or “Other” 1 (14.3) 6 (85.7) .150
Table 2. HPV* and HPV vaccine awareness and uptake.
*HPV, human papillomavirus; PCP, primary care provider; ED, emergency department. 
vaccine administration. Physician recommendation has been 
shown to be the most effective indicator of HPV uptake among 
vaccine-eligible women and may be equally effective in an 
ED setting.28-31 However, as Hill and Okugo demonstrated 
when assessing EP attitudes toward proposed HPV vaccine 
initiation in the ED, perceived barriers to HPV education and 
vaccine initiation in the ED setting do exist, including concerns 
regarding time requirements and reimbursement.32 Likewise, 
it is anticipated that some EPs may not embrace a preventative 
medicine role, a wheelhouse that traditionally has belonged to 
primary care physicians. 
EPs, however, as demonstrated by our survey responses, 
may represent the only healthcare encounters many women 
ever have. EDs, as part of the national public health safety 
net, frequently encounter subsets of the general population 
who often have minimal interaction with or limited access 
to the traditional primary care-based healthcare system.13,33 
Considering an expanded role for the EP, incorporating social 
determinants of health and their influence on our patients, 
beyond immediate stabilization and acuity, will be paramount to 
our patients’ health as well as general public health.
Initiating a conversation with EPs and primary care partners 
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and/or community resources may be an important consideration 
as the healthcare system attempts to address HPV from a public 
health perspective.34 Certainly it is interesting to note that the  
majority of survey respondents were amenable to HPV vaccine 
initiation in the ED.  
The ED setting has more recently been used as a venue 
for universal screening of other sexually transmitted viral 
infections, including HIV and HCV. Well established, opt-out 
screening programs of this type have resulted in the successful 
linkage of care of previously undiagnosed and untreated HIV- 
and/or HCV-positive patients, many of whom may have had no 
other access to testing or definitive care.14,15 Initiating a similar 
ED-based HPV vaccine awareness and initiation with a linkage 
to care program may be a way to bridge the existing HPV gaps 
in the US, particularly among racial and socioeconomic groups 
suffering from healthcare disparities. 
Future, more expansive studies, considering additional 
evaluation of the adolescent age range as well as male patients, 
would be useful to further characterize the at-risk population 
presenting routinely to the ED setting.  
LIMITATIONS
This is a single-center study, and as such, results may not 
be universally applicable to all ED settings. In addition, the 
results represent a convenience sample collected as a pilot 
study and may not reflect overall ED demographics. In certain 
instances (eg, Hispanic respondents), small response numbers 
may limit data interpretation. Likewise, demographic data on 
excluded patients, as well as those who refused participation, 
was not collected in this feasibility study, which may also 
limit its general applicability. Exclusion of population subsets, 
particularly non-English speaking individuals, may result in 
skewed data; however, the majority of non-English speaking 
patients presenting to our ED represent underserved minorities 
who face similar healthcare inequities to other minority groups, 
including decreased rates of HPV vaccination. Thus, we 
suspect that inclusion of their responses and data would likely 
contribute to disparities noted in the discussion above. Because 
survey answers were self-reported by respondents, there was 
a potential for recall bias and/or social desirability bias, which 
could have contributed to over- or under-inflation of personal 
medical history and/or risk factor reporting in particular. Finally, 
pediatric patients, an important patient subset, were excluded 
from our study. A nearby children’s hospital caters to the 
majority of local pediatric emergency patients, limiting pediatric 
patient exposure in the study ED. 
CONCLUSION
HPV awareness and vaccination rates in this female ED 
population were low while cervical-cancer risk factor rates were 
high, identifying a particularly vulnerable population. EDs may 
be a high-yield venue for HPV and cervical cancer prevention 
including education, screening, and vaccine initiation. 
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